BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 32401815)

  • 1. Low LEF1 expression is a biomarker of early T-cell precursor, an aggressive subtype of T-cell lymphoblastic leukemia.
    Wang M; Zhang C
    PLoS One; 2020; 15(5):e0232520. PubMed ID: 32401815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early T-cell precursor acute lymphoblastic leukemia/lymphoma (ETP-ALL/LBL) in adolescents and adults: a high-risk subtype.
    Jain N; Lamb AV; O'Brien S; Ravandi F; Konopleva M; Jabbour E; Zuo Z; Jorgensen J; Lin P; Pierce S; Thomas D; Rytting M; Borthakur G; Kadia T; Cortes J; Kantarjian HM; Khoury JD
    Blood; 2016 Apr; 127(15):1863-9. PubMed ID: 26747249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of JAK/STAT pathway inhibition in murine xenograft models of early T-cell precursor (ETP) acute lymphoblastic leukemia.
    Maude SL; Dolai S; Delgado-Martin C; Vincent T; Robbins A; Selvanathan A; Ryan T; Hall J; Wood AC; Tasian SK; Hunger SP; Loh ML; Mullighan CG; Wood BL; Hermiston ML; Grupp SA; Lock RB; Teachey DT
    Blood; 2015 Mar; 125(11):1759-67. PubMed ID: 25645356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early T-Cell Precursor Leukemia Has a Higher Risk of Induction-Related Infection among T-Cell Acute Lymphoblastic Leukemia in Adult.
    Huang K; Dai M; Li Q; Liu N; Lin D; Wang Q; Zhou X; Wang Z; Gao Y; Jin H; Liu X; Liu Q; Zhou H
    Mediators Inflamm; 2020; 2020():8867760. PubMed ID: 33424437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of adult patients with early T-cell precursor (ETP) acute lymphoblastic leukemia/lymphoma (ALL) and non-ETP T-ALL.
    Onishi Y; Furukawa E; Kamata M; Fukatsu M; Kameoka Y; Hatta S; Hamada H; Oyake T; Kai T; Sukegawa M; Nakajima S; Yanagiya R; Yamaguchi K; Takahashi T; Harazaki Y; Izumi T; Murai K; Ito S; Ikezoe T; Ishizawa K; Takahashi N; Harigae H
    Int J Hematol; 2023 May; 117(5):738-747. PubMed ID: 36757523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early T-Cell Precursor Leukemia: A High-Risk Subtype of Acute Lymphoblastic Leukemia, Single Center Experience in Jordan.
    Halahleh K; Muradi I; Khalil MZ; Halahleh L; Sughayer M; Kamal N; Sultan I; Alrabi K
    Clin Lymphoma Myeloma Leuk; 2023 Nov; 23(11):e411-e419. PubMed ID: 37730482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunophenotypic analysis of T-acute lymphoblastic leukemia. A CD5-based ETP-ALL perspective of non-ETP T-ALL.
    Chopra A; Bakhshi S; Pramanik SK; Pandey RM; Singh S; Gajendra S; Gogia A; Chandramohan J; Sharma A; Kumar L; Seth R; Rai S; Kumar R
    Eur J Haematol; 2014 Mar; 92(3):211-8. PubMed ID: 24329989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Outcome of 126 adolescent and adult T-cell acute leukemia/lymphoma patients and the prognostic significance of early T-cell precursor leukemia subtype].
    Liao HY; Sun ZY; Wang YX; Jin YM; Zhu HL; Jiang NG
    Zhonghua Xue Ye Xue Za Zhi; 2019 Jul; 40(7):561-567. PubMed ID: 32397018
    [No Abstract]   [Full Text] [Related]  

  • 9. MicroRNA profiling reveals aberrant microRNA expression in adult ETP-ALL and functional studies implicate a role for miR-222 in acute leukemia.
    Coskun E; Neumann M; Schlee C; Liebertz F; Heesch S; Goekbuget N; Hoelzer D; Baldus CD
    Leuk Res; 2013 Jun; 37(6):647-56. PubMed ID: 23522449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathological and immunophenotypic features of early T cell precursor acute lymphoblastic leukaemia: A flow cytometry score for the initial diagnosis.
    Chandra D; Singh MK; Gupta R; Rahman K; Yadav DD; Sarkar MK; Gupta A; Yadav S; Kashyap R; Nityanand S
    Int J Lab Hematol; 2021 Dec; 43(6):1417-1423. PubMed ID: 34115925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early T precursor acute lymphoblastic leukaemia/lymphoma shows differential immunophenotypic characteristics including frequent CD33 expression and in vitro response to targeted CD33 therapy.
    Khogeer H; Rahman H; Jain N; Angelova EA; Yang H; Quesada A; Ok CY; Sui D; Wei P; Al Fattani A; Pierce S; Loghavi S; Lamb A; Hu P; Thakral B; Kanagal-Shamanna R; Jorgensen JL; Jabbour EJ; Kantarjian HM; Medeiros LJ; Khoury JD
    Br J Haematol; 2019 Aug; 186(4):538-548. PubMed ID: 31115909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic and clinical characterization of early T-cell precursor lymphoblastic lymphoma.
    Xu X; Paxton CN; Hayashi RJ; Dunsmore KP; Winter SS; Hunger SP; Winick NJ; Carroll WL; Loh ML; Devidas M; Gross TG; Bollard CM; Perkins SL; Miles RR
    Blood Adv; 2021 Jul; 5(14):2890-2900. PubMed ID: 34297047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytogenetic and molecular characteristics and outcomes of adult patients with early T-cell precursor acute lymphoblastic leukemia.
    Yoon JH; Kim HS; Min GJ; Park SS; Park S; Lee SE; Cho BS; Eom KS; Kim YJ; Kim HJ; Min CK; Cho SG; Lee JW; Kim M; Kim Y; Lee S
    Eur J Haematol; 2023 Feb; 110(2):137-148. PubMed ID: 36217591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ezh2 Controls an Early Hematopoietic Program and Growth and Survival Signaling in Early T Cell Precursor Acute Lymphoblastic Leukemia.
    Danis E; Yamauchi T; Echanique K; Zhang X; Haladyna JN; Riedel SS; Zhu N; Xie H; Orkin SH; Armstrong SA; Bernt KM; Neff T
    Cell Rep; 2016 Mar; 14(8):1953-65. PubMed ID: 26904942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Characteristics and prognosis in adult patients with early T-cell precursor acute lymphoblastic leukemia].
    Gong XY; Wang Y; Liu BC; Wei H; Zhou CL; Lin D; Liu KQ; Wei SN; Gong BF; Zhang GJ; Liu YT; Zhao XL; Li Y; Gu RX; Qiu SW; Mi YC; Wang JX
    Zhonghua Xue Ye Xue Za Zhi; 2018 Dec; 39(12):977-982. PubMed ID: 30612397
    [No Abstract]   [Full Text] [Related]  

  • 16. B-cell lymphoma/leukaemia 11B (BCL11B) expression status helps distinguish early T-cell precursor acute lymphoblastic leukaemia/lymphoma (ETP-ALL/LBL) from other subtypes of T-cell ALL/LBL.
    Fang H; Wang W; El Hussein S; Morita K; Beird HC; Mitra A; Loghavi S; Lin P; Jabbour EJ; Khoury JD
    Br J Haematol; 2021 Sep; 194(6):1034-1038. PubMed ID: 34402058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-course Venetoclax With Standard Chemotherapy Is Effective in Early T-cell Precursor Acute Lymphoblastic Leukemia.
    Borah P; Dayal N; Pathak S; Naithani R
    J Pediatr Hematol Oncol; 2023 Jul; 45(5):271-274. PubMed ID: 37027330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early T-cell precursor leukemia: a subtype of high risk childhood acute lymphoblastic leukemia.
    Ma M; Wang X; Tang J; Xue H; Chen J; Pan C; Jiang H; Shen S
    Front Med; 2012 Dec; 6(4):416-20. PubMed ID: 23065427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracellular Cholesterol Pools Regulate Oncogenic Signaling and Epigenetic Circuitries in Early T-cell Precursor Acute Lymphoblastic Leukemia.
    Rashkovan M; Albero R; Gianni F; Perez-Duran P; Miller HI; Mackey AL; Paietta EM; Tallman MS; Rowe JM; Litzow MR; Wiernik PH; Luger S; Sulis ML; Soni RK; Ferrando AA
    Cancer Discov; 2022 Mar; 12(3):856-871. PubMed ID: 34711640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of lymphoid enhancer-binding factor-1 (LEF1) is a novel favorable prognostic factor in childhood acute lymphoblastic leukemia.
    Jia M; Zhao HZ; Shen HP; Cheng YP; Luo ZB; Li SS; Zhang JY; Tang YM
    Int J Lab Hematol; 2015 Oct; 37(5):631-40. PubMed ID: 25955539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.